Page last updated: 2024-08-24

topotecan and Esophageal Neoplasms

topotecan has been researched along with Esophageal Neoplasms in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Begg, AC; Bloom, G; Boulware, D; Calvin, DP; Eschrich, SA; Kelley, S; Lee, JH; Pramana, J; Rocha-Lima, C; Torres-Roca, JF; Yeatman, TJ; Zhang, H; Zhao, H	1
Aozasa, K; Doki, Y; Ikeda, J; Makino, T; Mamat, S; Morii, E; Qiu, Y; Rahadiani, N; Tian, T; Wang, Y	1
Adler, H; Buckley, M; Cho, J; Dar, K; Fry, D; Hochster, H; Kim, T; Liebes, L; Pease, D; Potmesil, M; Zeleniuch-Jacquotte, A	1
Asbury, RF; Baez, L; Benson, AB; Falkson, CI; Graham, D; Lipsitz, S	1
Conrad, M; Jacobson, JL; Ketchel, SJ; Kuebler, JP; Macdonald, JS; Mills, G; Rivkin, S; Taylor, S; Weiss, G	1
Clark, JW; Eder, JP; Huang, KC; Kwiatkowski, D; Lynch, T; Ng, SW; Ryan, DP; Seiden, MV; Skarin, A; Supko, JG	1

Trials

5 trial(s) available for topotecan and Esophageal Neoplasms

Article	Year
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. International journal of radiation oncology, biology, physics, 2009, Oct-01, Volume: 75, Issue:2 Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Cell Line, Tumor; Esophageal Neoplasms; Female; Gene Expression; Head and Neck Neoplasms; Humans; Linear Models; Male; Middle Aged; Models, Genetic; Oligonucleotide Array Sequence Analysis; Prognosis; Prospective Studies; Radiation Tolerance; Rectal Neoplasms; Topotecan	2009
Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:3 Topics: Adenoma, Islet Cell; Antineoplastic Agents; Autoantibodies; Autoantigens; Biomarkers; Biopsy; Breast Neoplasms; Cell Line; DNA Topoisomerases, Type I; Endometrial Neoplasms; Esophageal Neoplasms; Female; Gastrointestinal Neoplasms; HeLa Cells; Humans; Lung Neoplasms; Nuclear Proteins; Ovarian Neoplasms; Pancreatic Neoplasms; Scleroderma, Systemic; Stomach Neoplasms; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured	1998
Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293). American journal of clinical oncology, 2000, Volume: 23, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Topotecan	2000
A phase II trial of topotecan in esophageal carcinoma: a Southwest Oncology Group study (SWOG 9339). Investigational new drugs, 2000, Volume: 18, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Survival Analysis; Topotecan	2000
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:3 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; DNA Primers; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Safety; Topotecan; Treatment Outcome	2002

Other Studies

1 other study(ies) available for topotecan and Esophageal Neoplasms

Article	Year
Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Annals of surgical oncology, 2010, Volume: 17, Issue:5 Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Colony-Forming Units Assay; Esophageal Neoplasms; Female; Flow Cytometry; Gene Silencing; Humans; Immunoenzyme Techniques; Male; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tissue Array Analysis; Topotecan; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2010

Article

Year

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.

Annals of surgical oncology, 2010, Volume: 17, Issue:5

Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Colony-Forming Units Assay; Esophageal Neoplasms; Female; Flow Cytometry; Gene Silencing; Humans; Immunoenzyme Techniques; Male; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tissue Array Analysis; Topotecan; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010